Connor, Clark & Lunn Investment Management Ltd.
Position in DHR — Danaher Corp /De/
CIK 1596800
VANCOUVER, A1
Position in DHR
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$24,539,169
+$17,822,657 QoQ
Shares Held
129,426
+341.1% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 94.11169316829694.ToString("F0")%
Shared 0.ToString("F0")%
None 5.888306831703058.ToString("F0")%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Connor, Clark & Lunn Investment Management Ltd. holds $206,312,128 across 18 Diagnostics & Research names. DHR ranks #3 (11.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
|
134,838 | $64,747,859 | |
| 2 | ILMN |
Illumina, Inc.
|
202,742 | $24,989,978 | |
| 3 | DHR |
Danaher Corp /De/
This page
|
129,426 | $24,539,169 | |
| 4 | GH |
Guardant Health, Inc.
|
254,788 | $23,534,767 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
54,570 | $9,413,325 | |
| 6 | CSTL |
Castle Biosciences Inc
|
377,082 | $9,257,363 | |
| 7 | ADPT |
Adaptive Biotechnologies Corp
|
649,627 | $9,016,822 | |
| 8 | NEO |
Neogenomics Inc
|
938,052 | $6,960,345 |
All Filings in DHR
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,539,169 | 129,426 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $6,716,512 | 29,340 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $282,917 | 1,427 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $9,616,247 | 48,680 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $25,998,510 | 126,822 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $7,845,789 | 34,179 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $26,653,221 | 95,868 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $33,614,819 | 134,540 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $49,374,388 | 197,719 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $5,213,478 | 22,536 | Shares | Sole | 2024-02-09 | |
| 2023-06-30 | $33,967,240 | 159,646 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $82,206,146 | 367,912 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $29,917,867 | 127,147 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $179,520 | 784 | Shares | Sole | 2022-11-10 | |
| 2022-03-31 | $16,155,252 | 62,125 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $17,656,576 | 60,535 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $13,217,769 | 48,974 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $48,398,773 | 203,435 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $50,564,379 | 253,406 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $56,196,095 | 285,357 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $26,761,817 | 140,191 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $10,920,664 | 69,663 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||